Perioperative Beta-Blocker Supply and Survival in Women With Epithelial Ovarian Cancer and a History of Cardiovascular Conditions.
Katrina SpilsburyKaren M TuesleySallie-Anne PearsonMichael D CooryPeter DonovanChristopher B SteerLouise M StewartNirmala PandeyaSusan J JordanPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Perioperative supply of NSBBs appeared to confer a survival advantage for women age over 50 years with a history of cardiovascular conditions. Long-term clinical trials are required to confirm these findings.